The data indicates that high levels of LCK expression is associated with worse clinical outcomes in endometrioid ovarian cancer and expression of LCK is increased in endometrioid ovarian cancer [33]. The gene discussed is LCK; the disease is ovarian endometrioid adenocarcinoma.